Cardiac masses are rare, but remain an important component of cardio-oncology practice. These include benign tumors, malignant tumors (primary and secondary) and tumor-like conditions (e.g., thrombus, Lambl's excrescences, and pericardial cyst). The advent of multimodality imaging has enabled identification of the etiology of cardiac masses in many cases, especially in conjunction with information from clinical settings. This paper provides a comprehensive review of the epidemiology, clinical presentation, imaging, diagnosis, management, and outcomes of cardiac masses.
Keywords: CMR, cardiovascular magnetic resonance imaging; CT, computed tomography; FDG, fluorodeoxyglucose; PCT, primary cardiac tumor; PET, positron emission tomography; RT3DE, real-time 3-dimensional echocardiography; TEE, transesophageal echocardiography; TTE, transthoracic echocardiography; UEA, ultrasound-enhancing agent; cardiac masses; cardiac metastases; cardiac myxoma; cardiac sarcoma; cardiac tumors; papillary fibroelastoma; pericardial cyst; pericardial mesothelioma; pericardial tumors.
© 2020 The Authors.